SCHEMBL23975708

SCHEMBL23975708

CC(C)[C@H](C(O)NC(C)(C)C)N(C)c1nc(Cl)nc2c1CCC2

nearest known ligand 0.31

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 1/20 0.31
USP2 O75604 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23975781 0.81 NPSR1 (0.38) NPSR1USP2
SCHEMBL23975784 0.81 NPSR1 (0.38) NPSR1USP2
SCHEMBL24702143 0.80 ABCB1 (0.33) NPSR1
SCHEMBL23975757 0.78 NPSR1 (0.39) NPSR1USP2
SCHEMBL23976305 0.78 NPSR1 (0.39) NPSR1USP2
SCHEMBL23975799 0.78 PDE10A (0.36)
SCHEMBL23975951 0.76 NPSR1 (0.37) NPSR1USP2
SCHEMBL30225255 0.76 NPSR1 (0.37) NPSR1USP2
SCHEMBL23975849 0.76 USP2 (0.32) USP2
SCHEMBL24702114 0.74 NPSR1 (0.32) NPSR1USP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021222483-A1 METHODS OF USE FOR PYRIMIDINES AS FERROPORTIN INHIBITORS GLOBAL BLOOD THERAPEUTICS, INC. (US) 2021-11-04 WO disclosed